Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
Therapeutic Innovation & Regulatory Science · 2024
DOI: 10.1007/s43441-024-00671-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Hiroko Yaegashi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Clinical trials have become larger and more complex. Thus, eSource should be used to enhance efficiency. This study aimed to evaluate the impact of the multisite implementation of eSource direct data capture (DDC), which we define as eCRFs for direct data entry in this study, on efficiency by analyzing data from a single investigator-initiated clinical trial in oncology.
Methods
Operational data associated with the targeted study conducted in Japan was used to analyze time from data occurrence to data entry and data finalization, and number of visits to the site and time spent at the site by clinical research associates (CRAs). Additionally, simulations were performed on the change in hours at the clinical sites during the implementation of eSource DDC.
Results
No difference in time from data occurrence to data entry was observed between the DDC and the transcribed data fields. However, the DDC fields could be finalized 4 days earlier than the non-DDC fields. Additionally, although no difference was observed in the number of visits for source data verification (SDV) by CRAs, a comparison among sites that introduced eSource DDC and those that did not showed that the time spent at the site for SDV was reduced. Furthermore, the simulation results indicated that even a small amount of data to be collected or a small percentage of DDC-capable items may lead to greater efficiency when the number of subjects per site is significant.
Conclusions
The implementation of eSource DDC may enhance efficiency depending on the study framework and type and number of items to be collected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biostatistics, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
- A2 Healthcare Corporation, 1-4-12, Utsubohommachi, Nishi-Ku, Osaka, Japan.
- Clinical Research Data Center, Tohoku University Hospital, Miyagi, Japan.
- Kanagawa Prefectural Hospital Organization, Yokohama, Japan.
- Kanagawa Cancer Center, Yokohama, Japan.
- The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Hiroko Yaegashi
Zitieren
APA
Yaegashi, H., Hayashi, Y., Takeda, M., Chiu, S. W., Nakayama, H., Ito, H., Takano, A., Tsuboi, M., Teramoto, K., Suzuki, H., Kato, T., Yasui, H., Nagamura, F., Daigo, Y., & Yamaguchi, T. (2024). Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00671-0
Vancouver
Yaegashi H, Hayashi Y, Takeda M, Chiu SW, Nakayama H, Ito H, et al. Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00671-0
BibTeX
@article{Yaegashi2024,
author = {Yaegashi, Hiroko and Hayashi, Yukikazu and Takeda, Makoto and Chiu, Shih-Wei and Nakayama, Haruhiko and Ito, Hiroyuki and Takano, Atsushi and Tsuboi, Masahiro and Teramoto, Koji and Suzuki, Hiroyuki and Kato, Tatsuya and Yasui, Hiroshi and Nagamura, Fumitaka and Daigo, Yataro and Yamaguchi, Takuhiro},
title = {Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2024},
doi = {10.1007/s43441-024-00671-0}
}
EUVIMED